WNK2 and bladder transitional cell carcinoma: The PPAR signaling pathway, mitogen-activated protein kinase signaling pathway, P53 signaling pathway, and mTOR signaling pathway were associated with high risk in BLCA patients, whereas immune-related pathways were significantly enriched in a low-risk group (14).